Patrick James Orme

Array ( [id] => 4500745 [patent_doc_number] => 07919473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-05 [patent_title] => 'IRNA agents targeting VEGF' [patent_app_type] => utility [patent_app_number] => 11/340080 [patent_app_country] => US [patent_app_date] => 2006-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 74 [patent_no_of_words] => 51287 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/919/07919473.pdf [firstpage_image] =>[orig_patent_app_number] => 11340080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 63983 [patent_doc_number] => 07759319 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-20 [patent_title] => 'Oligomeric compounds and compositions for use in modulation of pri-mirnas' [patent_app_type] => utility [patent_app_number] => 11/329992 [patent_app_country] => US [patent_app_date] => 2006-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27464 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/759/07759319.pdf [firstpage_image] =>[orig_patent_app_number] => 11329992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5120598 [patent_doc_number] => 20070142313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-21 [patent_title] => 'MicroRNA1 therapies' [patent_app_type] => utility [patent_app_number] => 11/303862 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2240 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20070142313.pdf [firstpage_image] =>[orig_patent_app_number] => 11303862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655773 [patent_doc_number] => 20060141508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Cellular signaling pathway based assays, reagents and kits' [patent_app_type] => utility [patent_app_number] => 11/289377 [patent_app_country] => US [patent_app_date] => 2005-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11049 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0141/20060141508.pdf [firstpage_image] =>[orig_patent_app_number] => 11289377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374716 [patent_doc_number] => 20090312277 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Compositions And Methods For Reversing Or Preventing Resistance Of A Cancer Cell To A Cytotoxic Agent' [patent_app_type] => utility [patent_app_number] => 11/667905 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13687 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312277.pdf [firstpage_image] =>[orig_patent_app_number] => 11667905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4465106 [patent_doc_number] => 07935811 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'Apparatus and system having dry gene silencing compositions' [patent_app_type] => utility [patent_app_number] => 11/283484 [patent_app_country] => US [patent_app_date] => 2005-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 53 [patent_no_of_words] => 28015 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 290 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935811.pdf [firstpage_image] =>[orig_patent_app_number] => 11283484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5614415 [patent_doc_number] => 20060116343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Sphingosine kinase-1 mediates gene expression regulation of a monocyte chemoattractant protein-1 gene' [patent_app_type] => utility [patent_app_number] => 11/274971 [patent_app_country] => US [patent_app_date] => 2005-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15757 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116343.pdf [firstpage_image] =>[orig_patent_app_number] => 11274971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5875219 [patent_doc_number] => 20060166917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Differentiation and/or proliferation modulating agents and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/265898 [patent_app_country] => US [patent_app_date] => 2005-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 27909 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20060166917.pdf [firstpage_image] =>[orig_patent_app_number] => 11265898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786545 [patent_doc_number] => 20060205693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Antisense antiviral compounds and methods for treating a filovirus infection' [patent_app_type] => utility [patent_app_number] => 11/264444 [patent_app_country] => US [patent_app_date] => 2005-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 16931 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20060205693.pdf [firstpage_image] =>[orig_patent_app_number] => 11264444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5747509 [patent_doc_number] => 20060110440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Method and system for biasing cellular development' [patent_app_type] => utility [patent_app_number] => 11/258360 [patent_app_country] => US [patent_app_date] => 2005-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 7923 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110440.pdf [firstpage_image] =>[orig_patent_app_number] => 11258360 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5136456 [patent_doc_number] => 20070078085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-05 [patent_title] => 'Methods and compositions for the utilization and targeting of osteomimicry' [patent_app_type] => utility [patent_app_number] => 11/248337 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 58326 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20070078085.pdf [firstpage_image] =>[orig_patent_app_number] => 11248337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5656496 [patent_doc_number] => 20060142232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Oligomeric compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/251564 [patent_app_country] => US [patent_app_date] => 2005-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 30152 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142232.pdf [firstpage_image] =>[orig_patent_app_number] => 11251564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710459 [patent_doc_number] => 20060051804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Oligonucleotides labeled with stable isotopes and a method for detecting the same' [patent_app_type] => utility [patent_app_number] => 11/248852 [patent_app_country] => US [patent_app_date] => 2005-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 4726 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20060051804.pdf [firstpage_image] =>[orig_patent_app_number] => 11248852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4487613 [patent_doc_number] => 07884196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-08 [patent_title] => 'Vaccine composition comprising methylated DNA and immunomodulatory motifs' [patent_app_type] => utility [patent_app_number] => 11/244142 [patent_app_country] => US [patent_app_date] => 2005-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 22501 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/884/07884196.pdf [firstpage_image] =>[orig_patent_app_number] => 11244142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5807691 [patent_doc_number] => 20060094045 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Macrocyclic chelators for gene-silencing or gene disruption' [patent_app_type] => utility [patent_app_number] => 11/251542 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6280 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094045.pdf [firstpage_image] =>[orig_patent_app_number] => 11251542 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5638082 [patent_doc_number] => 20060069056 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-30 [patent_title] => 'Oligoribonucleotides and methods of use thereof for treatment of alopecia, acute renal failure and other diseases' [patent_app_type] => utility [patent_app_number] => 11/237598 [patent_app_country] => US [patent_app_date] => 2005-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14125 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20060069056.pdf [firstpage_image] =>[orig_patent_app_number] => 11237598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6320314 [patent_doc_number] => 20100113332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'METHOD OF TREATING AN INFLAMMATORY DISEASE BY DOUBLE STRANDED RIBONUCLEIC ACID' [patent_app_type] => utility [patent_app_number] => 11/576139 [patent_app_country] => US [patent_app_date] => 2005-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 25714 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113332.pdf [firstpage_image] =>[orig_patent_app_number] => 11576139 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718622 [patent_doc_number] => 20080241144 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Prohibitin as Target for Cancer Therapy' [patent_app_type] => utility [patent_app_number] => 11/663591 [patent_app_country] => US [patent_app_date] => 2005-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11827 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241144.pdf [firstpage_image] =>[orig_patent_app_number] => 11663591 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5813941 [patent_doc_number] => 20060084094 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Conjugates for use in hepatocyte free uptake assays' [patent_app_type] => utility [patent_app_number] => 11/221001 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 25531 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084094.pdf [firstpage_image] =>[orig_patent_app_number] => 11221001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 111934 [patent_doc_number] => 07718624 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-18 [patent_title] => 'Modulation of immune response and inflammation by targeting hypoxia inducible factors' [patent_app_type] => utility [patent_app_number] => 11/215224 [patent_app_country] => US [patent_app_date] => 2005-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10102 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/718/07718624.pdf [firstpage_image] =>[orig_patent_app_number] => 11215224 [rel_patent_id] =>[rel_patent_doc_number] =>)